Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Merck's Keytruda therapy with chemotherapy failed Phase 3 trial for high-risk endometrial cancer disease-free survival.
Merck's Keytruda therapy in combination with chemotherapy failed to meet the main goal of disease-free survival in high-risk endometrial cancer patients after surgery in a Phase 3 trial.
The study's other main goal of overall survival was not formally tested due to the trial's failure.
Endometrial cancer begins in the uterus's inner lining and is the most common form affecting the organ.
5 Articles
La terapia Keytruda de Merck con quimioterapia fracasó en el ensayo de fase 3 para la supervivencia libre de enfermedad del cáncer de endometrio de alto riesgo.